A randomized, double-blind, double-dummy, active- and placebo-controlled, four-way crossover study assessing pharmacodynamics and pharmacokinetics of crushed intranasal oxycodone ARIR compared with crushed intranasal IR oxycodone and intact oral oxycodone ARIR
Latest Information Update: 05 Sep 2019
At a glance
- Drugs Oxycodone (Primary) ; Oxycodone
- Indications Pain
- Focus Pharmacodynamics
Most Recent Events
- 05 Sep 2019 New trial record